Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
CA 2082928 C · Owner: Amylin Pharmaceuticals, Inc. · Inventors: Beaumont, Kevin; Young, Andrew A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for treatment of hypoglycemic conditions by administering a calcitonin alone or in combination with glucagon and/or an amylin, and related compositions.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 13, 1992 and granted September 5, 2000. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 13, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 13, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.